Efficacy and safety of dupilumab for atopic dermatitis in a renal transplant patient

Saved in:
Bibliographic Details
Published in:Annales de dermatologie et de vénéréologie 2024-06, Vol.151 (2), p.103259, Article 103259
Main Authors: Randriamiarana, T., Boutin, D., Thierry, A., Lecron, J.-C., Hainaut, E., Masson Regnault, M.
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal, Humanized - adverse effects
Antibodies, Monoclonal, Humanized - therapeutic use
Dermatitis, Atopic - drug therapy
Humans
Immunosuppressive Agents - adverse effects
Immunosuppressive Agents - therapeutic use
Kidney Transplantation
Male
Middle Aged
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c311t-bc7064ccf73aba07e50b627b065401fb83980e4c01a0975ce732280c0381f0923
container_end_page
container_issue 2
container_start_page 103259
container_title Annales de dermatologie et de vénéréologie
container_volume 151
creator Randriamiarana, T.
Boutin, D.
Thierry, A.
Lecron, J.-C.
Hainaut, E.
Masson Regnault, M.
description
doi_str_mv 10.1016/j.annder.2024.103259
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2973105435</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0151963824000152</els_id><sourcerecordid>2973105435</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-bc7064ccf73aba07e50b627b065401fb83980e4c01a0975ce732280c0381f0923</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhnNQbK3-A5EcvWydJJvd7EWQUj-g4KWeQzabQMp-mWSF_ntTtnr0NDDzvvPOPAjdEVgTIMXjYa36vjF-TYHmqcUory7QEggnWVUwsUDXIRwACBWMX6EFExzKiosl2m-tdVrpI1Z9g4OyJh7xYHEzja6dOlVjO3is4jA6jVNCp6KLLmDXY4W96VWLo1d9GFvVRzymqenjDbq0qg3m9lxX6PNlu9-8ZbuP1_fN8y7TjJCY1bqEItfalkzVCkrDoS5oWUPBcyC2FqwSYHINREFVcm1KRqkADUwQCxVlK_Qw7x398DWZEGXngjZtusUMU5C0KhkBnjOepPks1X4IwRsrR-865Y-SgDwxlAc5M5QnhnJmmGz354Sp7kzzZ_oFmARPs8CkP79dsgedEGjTOG90lM3g_k_4AYmYhbM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2973105435</pqid></control><display><type>article</type><title>Efficacy and safety of dupilumab for atopic dermatitis in a renal transplant patient</title><source>ScienceDirect Journals</source><creator>Randriamiarana, T. ; Boutin, D. ; Thierry, A. ; Lecron, J.-C. ; Hainaut, E. ; Masson Regnault, M.</creator><creatorcontrib>Randriamiarana, T. ; Boutin, D. ; Thierry, A. ; Lecron, J.-C. ; Hainaut, E. ; Masson Regnault, M.</creatorcontrib><identifier>ISSN: 0151-9638</identifier><identifier>DOI: 10.1016/j.annder.2024.103259</identifier><identifier>PMID: 38507958</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Antibodies, Monoclonal, Humanized - adverse effects ; Antibodies, Monoclonal, Humanized - therapeutic use ; Dermatitis, Atopic - drug therapy ; Humans ; Immunosuppressive Agents - adverse effects ; Immunosuppressive Agents - therapeutic use ; Kidney Transplantation ; Male ; Middle Aged</subject><ispartof>Annales de dermatologie et de vénéréologie, 2024-06, Vol.151 (2), p.103259, Article 103259</ispartof><rights>2024 Elsevier Masson SAS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c311t-bc7064ccf73aba07e50b627b065401fb83980e4c01a0975ce732280c0381f0923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38507958$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Randriamiarana, T.</creatorcontrib><creatorcontrib>Boutin, D.</creatorcontrib><creatorcontrib>Thierry, A.</creatorcontrib><creatorcontrib>Lecron, J.-C.</creatorcontrib><creatorcontrib>Hainaut, E.</creatorcontrib><creatorcontrib>Masson Regnault, M.</creatorcontrib><title>Efficacy and safety of dupilumab for atopic dermatitis in a renal transplant patient</title><title>Annales de dermatologie et de vénéréologie</title><addtitle>Ann Dermatol Venereol</addtitle><subject>Antibodies, Monoclonal, Humanized - adverse effects</subject><subject>Antibodies, Monoclonal, Humanized - therapeutic use</subject><subject>Dermatitis, Atopic - drug therapy</subject><subject>Humans</subject><subject>Immunosuppressive Agents - adverse effects</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Kidney Transplantation</subject><subject>Male</subject><subject>Middle Aged</subject><issn>0151-9638</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LAzEQhnNQbK3-A5EcvWydJJvd7EWQUj-g4KWeQzabQMp-mWSF_ntTtnr0NDDzvvPOPAjdEVgTIMXjYa36vjF-TYHmqcUory7QEggnWVUwsUDXIRwACBWMX6EFExzKiosl2m-tdVrpI1Z9g4OyJh7xYHEzja6dOlVjO3is4jA6jVNCp6KLLmDXY4W96VWLo1d9GFvVRzymqenjDbq0qg3m9lxX6PNlu9-8ZbuP1_fN8y7TjJCY1bqEItfalkzVCkrDoS5oWUPBcyC2FqwSYHINREFVcm1KRqkADUwQCxVlK_Qw7x398DWZEGXngjZtusUMU5C0KhkBnjOepPks1X4IwRsrR-865Y-SgDwxlAc5M5QnhnJmmGz354Sp7kzzZ_oFmARPs8CkP79dsgedEGjTOG90lM3g_k_4AYmYhbM</recordid><startdate>202406</startdate><enddate>202406</enddate><creator>Randriamiarana, T.</creator><creator>Boutin, D.</creator><creator>Thierry, A.</creator><creator>Lecron, J.-C.</creator><creator>Hainaut, E.</creator><creator>Masson Regnault, M.</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202406</creationdate><title>Efficacy and safety of dupilumab for atopic dermatitis in a renal transplant patient</title><author>Randriamiarana, T. ; Boutin, D. ; Thierry, A. ; Lecron, J.-C. ; Hainaut, E. ; Masson Regnault, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-bc7064ccf73aba07e50b627b065401fb83980e4c01a0975ce732280c0381f0923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antibodies, Monoclonal, Humanized - adverse effects</topic><topic>Antibodies, Monoclonal, Humanized - therapeutic use</topic><topic>Dermatitis, Atopic - drug therapy</topic><topic>Humans</topic><topic>Immunosuppressive Agents - adverse effects</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Kidney Transplantation</topic><topic>Male</topic><topic>Middle Aged</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Randriamiarana, T.</creatorcontrib><creatorcontrib>Boutin, D.</creatorcontrib><creatorcontrib>Thierry, A.</creatorcontrib><creatorcontrib>Lecron, J.-C.</creatorcontrib><creatorcontrib>Hainaut, E.</creatorcontrib><creatorcontrib>Masson Regnault, M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annales de dermatologie et de vénéréologie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Randriamiarana, T.</au><au>Boutin, D.</au><au>Thierry, A.</au><au>Lecron, J.-C.</au><au>Hainaut, E.</au><au>Masson Regnault, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy and safety of dupilumab for atopic dermatitis in a renal transplant patient</atitle><jtitle>Annales de dermatologie et de vénéréologie</jtitle><addtitle>Ann Dermatol Venereol</addtitle><date>2024-06</date><risdate>2024</risdate><volume>151</volume><issue>2</issue><spage>103259</spage><pages>103259-</pages><artnum>103259</artnum><issn>0151-9638</issn><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>38507958</pmid><doi>10.1016/j.annder.2024.103259</doi></addata></record>
fulltext fulltext
identifier ISSN: 0151-9638
ispartof Annales de dermatologie et de vénéréologie, 2024-06, Vol.151 (2), p.103259, Article 103259
issn 0151-9638
language eng
recordid cdi_proquest_miscellaneous_2973105435
source ScienceDirect Journals
subjects Antibodies, Monoclonal, Humanized - adverse effects
Antibodies, Monoclonal, Humanized - therapeutic use
Dermatitis, Atopic - drug therapy
Humans
Immunosuppressive Agents - adverse effects
Immunosuppressive Agents - therapeutic use
Kidney Transplantation
Male
Middle Aged
title Efficacy and safety of dupilumab for atopic dermatitis in a renal transplant patient
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T10%3A59%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20and%20safety%20of%20dupilumab%20for%20atopic%20dermatitis%20in%20a%20renal%20transplant%20patient&rft.jtitle=Annales%20de%20dermatologie%20et%20de%20v%C3%A9n%C3%A9r%C3%A9ologie&rft.au=Randriamiarana,%20T.&rft.date=2024-06&rft.volume=151&rft.issue=2&rft.spage=103259&rft.pages=103259-&rft.artnum=103259&rft.issn=0151-9638&rft_id=info:doi/10.1016/j.annder.2024.103259&rft_dat=%3Cproquest_cross%3E2973105435%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c311t-bc7064ccf73aba07e50b627b065401fb83980e4c01a0975ce732280c0381f0923%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2973105435&rft_id=info:pmid/38507958&rfr_iscdi=true